RA
ELAN icon

Royce & Associates’s Elanco Animal Health ELAN Stock Holding History

Royce & Associates’s Portfolio ELAN Stock Details ELAN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-469,916
Closed -$11.2M – 778
2026
Q1 		$11.2M Sell
469,916
-25,010
-5% -$611K 0.11% 294
2025
Q4 		$11.2M Sell
494,926
-107,638
-18% -$2.34M 0.11% 274
2025
Q3 		$12.1M Buy
602,564
+105,632
+21% +$1.77M 0.12% 252
2025
Q2 		$7.1M Buy
+496,932
New +$5.81M 0.07% 392

Other funds holding ELAN

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Winslow Capital Management
Winslow Capital Management Minneapolis, Minnesota $29.1B AUM 43.86% 1-Year Est. Return

Royce & Associates's ELAN Position: Q2 2026 in Review

Royce & Associates sold out of Elanco Animal Health (ELAN) in Q2 2026, closing a stake of 469,916 shares — an estimated $11.2M sold.

Royce & Associates first reported a position in ELAN in Q2 2025 and held it in 4 quarters. The position peaked at $12.1M in Q3 2025. 520 funds tracked by Wall St. Rank hold ELAN as of Q2 2026.

  • Royce & Associates reported no remaining Elanco Animal Health position as of Q2 2026 after selling out during the quarter.
  • Royce & Associates sold 469,916 Elanco Animal Health shares in Q2 2026, an estimated $11.2M.
  • Royce & Associates first reported a position in Elanco Animal Health in Q2 2025 and held it in 4 quarters.
  • Royce & Associates's Elanco Animal Health position peaked at $12.1M in Q3 2025.
  • 520 funds tracked by Wall St. Rank held Elanco Animal Health as of Q2 2026.

Based on Royce & Associates's 13F filing for Q2 2026, filed 14 Aug 2026.